| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8667804 | Journal of Cardiology | 2018 | 8 Pages |
Abstract
Our data suggest AKI affects over half of all patients who undergo TA, and has a major and long-lasting impact on survival, MACE, and heart failure. Use of AKIN and KDIGO is more useful than the RIFLE criteria when determining the prognostic value of AKI for mortality beyond 30 days.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mei-Zhen MD, Yan MD, Wing-Kok MBBS, FCSHK, Daniel MBBS, FCSHK, Ko-Yung MBBS, FCSHK, Kar-Lai MBBS, FCSHK, Lai-Ming PhD, Yui-Ming MBBS, Chu-Pak MD, Tak-Mao MD, Hung-Fat MD, PhD, Kai-Hang MD, PhD,